Antibiotic resistance: National actions contribute to a global solution NEPAL Professor Paras K Pokharel Vice Chair GARP Nepal.

Slides:



Advertisements
Similar presentations
India Injection Safety Coalition. If you have an apple and I have an apple and we exchange these apples then you and I will still each have one apple.
Advertisements

Engaging All Care Providers in S.E Asia Region A pproach to Health Systems Strengthening Jan Voskens. IUATLD Paris, 31 October 2006.
Healthcare Waste Management Programme
Foodborne Outbreak Investigation, Hanoi, Vietnam 01 – 05 June 2009 Foodborne Diseases Integrating efforts from feed to food Dr Danilo Lo Fo Wong.
Lobbying for Food Security: FAO advocacy interventions
Antimicrobial resistance “One health fits all”
Antibiotic Policy in Ghana; the way forward
Essential Drugs Programme
Edo Agustian Indonesian Drug Users Network Experiencing HCV Infection – the treatment, the reality and the possibilities for Cure.
Departmental Perspectives on Viral Hepatitis
Global and National Response to AMR Chatham House/Murdoch University AMR Symposium Chris Baggoley 8 December 2014.
Krishna Gautam National Council on Independent Living Nepal (NCILN) and CIL Kathmandu.
Prevention and Control of Viral Hepatitis Infection: WHO Framework for Global Action Prevention and Control of Viral Hepatitis Infection: WHO Framework.
DON’T FORGET THE ‘E’ IN “MORPHINE” International Pain Policy Fellowship: Advocacy & Communications.
COUNTRY PRESENTATION (DRUGS AND HIV/AIDS)– Nepal Dr. Krishna Kumar Rai, Director National Centre for AIDS and STD Control, Ministry of Health and Population.
RMC Advocacy: From Charter to Country- level Efforts Mande Limbu WRA June 24, 2014 HPP strengthens maternal health.
Injecting Drug Use and Drug Led HIV in Nepal Bijay Pandey Recovering Nepal.
TB DIAGNOSTICS R&D: Not Just Technology Peter Mehlape, General Manager GBC Southern Africa Conference 11th October 2010, Johannesburg BD Experience with.
Promoting patient-centred healthcare around the world Patient Engagement in Patient Safety Jolanta Bilińska Secretary and Governing Board Member IAPO President.
PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.
TASK FORCE ON RETOOLING STOP TB PARTNERSHIP Cape Town November 2007.
A mixed model to promote rational use of medicines Nithima Sumpradit (1,2); Pisonthi Chongtrakul (3); Kunyada Anuwong (4); Somying Pumtong (4) 1: Food.
Infection Control Clinical Pharmacy and Patient Safety
International collaboration in Afghanistan education system Written by Shah Syed Sher Presented by Sedqiyar Manila April 20 th 2006 Tokyo University.
National antibiotic program in the Czech Republic NAP-CZ Vlastimil Jindrák and Subcommitte for antibiotic policy ČLS JEP.
1 OIE Response to the HPAI Threat in the SADC Region 1 st SADC Meeting on Avian Influenza Pretoria, South Africa 7-9 March 2006 Sub Regional Representation.
Pandemic Response and current activities in Lao PDR NIC Meeting, Beijing, Aug 2009 Dr Phengta Vongphrachanh Director National centre for Laboratory.
Capacity-Building for Country- and Regional- Level Advocacy and Interventions to Contain Antimicrobial Resistance in Africa Mohan P. Joshi*, Terry Green*,
An International Conference that Examines the Issues of Yesterday, the Challenges of Today, and the Opportunities for Tomorrow SARS: Crisis and Opportunity.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.
 Civil Society is understood to encompass all associations formal and informal that are outside the state and the private market sector. They are associations,
Progress and plans for PPM in the WHO Region of the Americas Fifth PPM Subgroup Meeting June, Cairo.
Towards a National Alliance against Chronic Respiratory Diseases Nikolai Khaltaev, MD, PhD March 2006, GARD General Meeting, Beijing, China.
Annual Meeting of the ASADI – Science Academies as Partners for Improving the Impact of Policies in Africa Session V: Partnership Themes for Development.
1 Combating Drug Resistance Syed Khalid Saeed Bukhari.
Exploring financing options NATIONAL TB CONTROL OF VIETNAM.
1/28/2016 Prevention Research and Natioanl Aids Plans Geneva 1 Prevention Research and National AIDS Plans June 2005 Geneva, Switzerland Prof. Roy.
Perspectives on containing antimicrobial resistance – ways to go … Karl Ekdahl, Strategic Advisor on behalf of Zsuzsanna Jakab, Director European Centre.
Ministerial Declaration and Concluding Remarks MD PhD Karin Tegmark Wisell Chair AMR expert group, NDPHS.
Prof. William Bazeyo One Health Central and Eastern Africa (OHCEA) One Health Conference –Libreville, Gabon 12 th -15th November 2012.
Bulgarian National Hepatitis Plan and Compassionate Use Regulations Dr. Stanimir Hasardzhiev Executive Director, ELPA Chairperson, Hepasist REPUBLIC OF.
Antibiotic resistance: national actions contribute to a global solution NEPAL Ram Janam Chaudhary Minister of Health Nepal.
Universal Patients’ Rights Association UPRA Decreasing Violation of Patients’ Rights (in the northern part of Cyprus) Rome, 4 of March, 2016.
Coordinator of Project management Unit of Global fund and MAP projects
1. SUSTAINABLE ANIMAL PRODUCTION The future of the farmers 2.
UHC 2030 CSO engagement mechanism Bruno Rivalan IHP+ Northern CSO Representative IHP+ Steering committee 21 th June 2016.
Engaging CSOs in UHC 2030 Bruno Rivalan IHP+ Northern CSO Representative IHP+ Steering committee 21 th June 2016.
Climate change and health: impacts, existing policies and programs, challenges and opportunities Ramkrishna Adhikari Under-Secretary Ministry of Health.
Antimicrobial Resistance in Poland - a state of affairs and prevention Danuta O. Lis the Ministry of Health, Poland 11th NDPHS PAC side event, 19th November.
WHO Regional Office for Europe
AMR containment in Thailand
Antibiotic Policy in Ghana; the way forward
Research on Antimicrobial Resistance
John Dogba, National One Health Technical Advisor, Liberia
Tackling antimicrobial resistance and improving antibiotic prescribing
Promoting Drug and Therapeutics Committees in the Developing World
WHO Medicines Work in Countries: The Kenya Example
How does teamwork improve value. Dr Nils E
IFOAM organizations Brief overview of IFOAM Organics International, IFOAM EU Group and IFOAM AgriBioMediterraneo.
Public support to PGS development
ECOANTIBIO Containment of Antimicrobial Resistance (AMR): actions and lessons from the Veterinary Sector in France.
Edo Agustian Indonesian Drug Users Network
Declaration of the 11th ministerial-level PAC meeting in Berlin 2015 From strategies to action – how to tackle the challenges of Antimicrobial Resistance.
Do Khang Chien, MD, PhD Nguyen Thi Phuong Cham,BSPh
Antibiotic Resistance: Strategic Solutions
“An overview” 10th April 2018 at MOH SMT Now 27th April 2018 at NPHIL
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
Essential Drugs and Medicines Policy
Essential Drugs and Medicines Policy
ICARS International Centre for Antimicrobial Resistance Solutions
Presentation transcript:

Antibiotic resistance: National actions contribute to a global solution NEPAL Professor Paras K Pokharel Vice Chair GARP Nepal

AMR Activities in Nepal: How it Began 1978: GoN, Drug Act 1995: GoN, National Drug Policy, Nepal 1998: GoN, Infectious Disease Control Program launched – to develop a sustainable national surveillance of AMR 1999: GoN, NPHL started Laboratory Based AMR Surveillance – Network of 13 laboratories 1999: APUA (Alliance for Prudent Use of Antibiotics) – Nepal was formed 2001: National Drug Policy Amended- “prudent use of antibiotics added” 2013: Global Antibiotic Resistance Partnership (GARP)-Nepal was formed; CDDEP & NPHF collaboration 2014: GoN, National Antibiotics Treatment Guidelines

Before GARP Nepal APUA Nepal – Started with Assisting GoN with drafting of National Antibiotic Policy (Major Contributor) – Pharmacologist & Microbiologists mostly from Kathmandu – Prudent use of Antibiotics; Major Focus Laboratory Surveillance : NPHL – Laboratory Based Surveillance Network ; Many hospitals around the country (Training Laboratorians, Quality Assuarance)

GARP Nepal GARP: International network that sensitizes AMR issues locally and gives Nepal a voice in antibiotic resistance in the international arena. GARP-Nepal Working Group formed 2013 – Civil Society, National Public Health Body Engagement: NPHF – Academicians/Practitioners in Public Health, Medicine, Microbiology, Policy, Lab Science, Veterinary Medicine, from all over the country.

GARP Nepal Long-term goal: – To lay the groundwork for a national action plan for antibiotic resistance in Nepal Specific objectives: – Carry out situation analysis of antibiotic use, resistance and related topics—human and animal—in Nepal – Develop Policy Brief(s) for mitigating antibiotic resistance in humans and animals

AMR This is not just about rational use of drugs. Not confined to hospital practice and medical specialty. Broadly anything that reduces the need for antibiotics will reduce antibiotic resistance.

AMR Vaccines (both antibacterial and antiviral) Clean water Sewage Disposal Rapid Diagnostics (reliable ones, not Widal tests, more like Gene Xpert vs AFB stains) Sub therapeutic use of Antibiotics in Animal/bird/fish farming Phasing out widespread use of antibiotics in poultry, cattle and fish farms.

AMR Hospitals are not “off the hook” Hospital-acquired infections are the most resistant: NDM1, for example. Hand washing between patients ( Not standard practice in Nepal) Antibiotics “ just in case”

GARP-Nepal Situation Analysis, 2014 Respiratory infections (one-half of the cases were resistant) Diarrhea (one-third of the cases were resistant) Bloodstream infections, STDs, UTI: no better

GARP-Nepal Situation Analysis, 2014 “By prescription only” laws have limited usefulness in Nepal Not enough for only a small group of people to know about AMR. Health care workers at all levels, ( humans and veterinarians) in collaboration with professionals and policy makers. Government support is critical.

GARP-Nepal Situation Analysis, 2014 Multi-sectoral engagement – Health Academia/Research – Medical Practitioners/ Lab Scientists – Agriculture/Veterinary Sectors – Policy Makers – Ministry of Health Owned Health Sciences Universities Policy Advocacy one of the objectives Engaging Government support at Ministerial Level Global Network – Celebrated Global Antibiotics Awareness Week 2015 – Health Sciences University, Agricultural University & Civil Society Engagement in Awareness & Campaigns

Working with Government Autonomous/Semiautonomous Govt bodies represented on GARP-Nepal Working Group GoN, MoHP on board since 2014, since the Situation Analysis was launched. Interest of MoH remains; supported by current minister as well

Challenges Political Instability / Humanitarian crisis National Health Policy 2071 (2014) Implementation plan for transition between the old policy and new policy Lack of National coordination body mandated by Government

Way Forward Engagement of local stakeholders Community based research – Participatory (Qualitative) research – Behavior change Initiatives for people/drug shops Generate more research from animal/fish sectors Partner with existing rational drug use & laboratory surveillance networks esp. National Public Health Laboratory, GoN Engage more private sector health groups

Way Forward National Action Plan for Antibiotic Resistance Collaborative, covering all sectors, building on GARP framework

Mount Fish Tail

Thank you